Low impact
An FDA advisory panel has backed wider access to six peptide therapies, citing concerns about the grey market.
ZeroHedge07/29, 11:05 PM
- Six
Figures as quoted by ZeroHedge
Related assets
Coming up for XBI
Explore next
Latest XBI news
Jin1008/19, 08:12 PM
iShares Biotechnology ETF rose 3.2% and State Street SPDR S&P Biotech ETF rose 2.9%.
FirstSquawk07/17, 01:16 AM
FirstSquawk07/16, 07:47 AM
A Senate bill aims to reduce US reliance on China in the drug industry.